For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of this treatment and Tafamidis meglumine represents a significant advancement . These innovative therapies stabilize the transthyretin protein, preventing its destructive build-up and reducing the severity of the disease . People are now r